<DOC>
	<DOCNO>NCT02612909</DOCNO>
	<brief_summary>The purpose study determine safe effective dose IVAC A/H5N1 vaccine licensure Vietnam . The first phase ( Phase 2 ) compare two dos vaccine . Based outcome Phase 2 , Vietnam MOH determine Phase 3 conduct .</brief_summary>
	<brief_title>A Safety Immunogenicity Study IVACFLU-A/H5N1</brief_title>
	<detailed_description>This Phase 2/3 , double-blind , randomize , placebo-controlled trial test safety immunogenicity two dos give 21 day apart IVAC A/H5N1 vaccine . In Phase 2 study , 300 healthy adult subject randomize receive 15 mcg vaccine ( n=100 ) , 30 mcg vaccine ( n=100 ) , saline placebo ( n=100 ) . Safety immunogenicity assess 300 subject . Although full evaluation safety continue Day 91 , early evaluation safety immunogenicity data collect Day 43 Phase 2 determine whether proceed Phase 3 dose select . A vaccine dose select base safety immunogenicity use pre-specified criterion . The conduct Phase 3 dependent show Hemagglutination Inhibition ( HAI ) response titer â‰¥1:40 60 % vaccine recipient least one two vaccine group Phase 2 . The dose select Phase 2 use Phase 3 trial . Phase 3 confirmatory study expand safety immunogenicity large number subject meet product registration Vietnam . In Phase 3 , subject randomize receive vaccine dose select Phase 2 ( n=1,000 ) saline placebo ( n=500 ) double blind . Safety assess subject immunogenicity measure subset approximately 300 subject receive IVACFLU-A/H5N1 ( vaccinee ) 500 subject enrol one 3 study site ( Hai Phong ) Phase 3 . All subject Phase 2 Phase 3 receive two injection A/H5N1 vaccine placebo , 21 day apart . Subjects male female healthy adult 18 60 year age .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male Female age 1860 year old literate healthy willing complete Diary Cards , Women : willing use effective birth control Day 43 history asthma hypersensitivity previous vaccine guillainbarre pregnant breastfeeding symptom report tuberculosis selfreport Human Immunodeficiency virus ( HIV ) self report hepatitis B ( HBV ) hepatitis C ( HCV ) self report active tuberculosis symptom active tuberculosis history cancer chronic use corticosteroid participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Avian Influenza</keyword>
	<keyword>A/H5N1 vaccine</keyword>
	<keyword>IVAC</keyword>
</DOC>